Radiopharmaceuticals and Tracers

The past year saw the release of several new, innovative technologies to improve nuclear imaging in both positron emission tomography (PET) and single-photon emission computed tomography (SPECT). 

Neuraceq, florbetaben, F18, F-18, Piramal, alzheimer's

The U.S. Food and Drug Administration (FDA) has approved a third beta-amyloid plaque positron emission tomography (PET) imaging radiotracer to identify Alzheimer’s disease. The FDA’s approval of Piramal Imaging’s Neuraceq (florbetaben F-18 injecti...

PET vs. SPECT, nuclear imaging advances

Just when positron emission tomography (PET) appears to be eclipsing single photon emission computed tomography (SPECT) for cardiac imaging, new advances make SPECT more attractive. Both modalities also have suffered setbacks with radiopharmaceuti...

August 27, 2014 — Telik Inc., a clinical stage oncology drug development company that merged with MabVax Therapeutics Inc. on July 8, announced it has...
NorthStar Medical Radioisotopes LLC signed a non-exclusive letter of intent with GE Healthcare, a division of General Electric Co., marking further progress...
August 20, 2014 — Three out of four people would want to know what kind of neurological disorder they had, even if there was no cure, according to new global...
First U.S. Commercial Neuraceq Scan Beta-amyloid Plaque Imaging  WVU Healthcare
Piramal Imaging announced that WVU Healthcare in West Virginia, is the first center in the United States to perform commercial scans using Neuraceq. 
Navidea Biopharmaceuticals’ Lymphoseek (technetium Tc-99m tilmanocept) injection is a radioactive diagnostic imaging agent, approved by the
Siemens Healthcare's syngo.via for molecular imaging is a reading solution that transforms large amounts of data into comprehensive results...
GE Healthcare's Discovery* IQ^ PET/CT (positron emission tomography/computed tomography) system enable both outstanding image quality and...

Articles

June 13, 2014 — The U.S. Food and Drug Administration (FDA) today approved a new use for Navidea Biopharmaceuticals’ Lymphoseek (technetium Tc-99m tilmanocept...
myocardial perfusion, PET/CT, Siemens, Biograph, mCT
The past year saw the release of several new, innovative technologies to improve nuclear imaging in both positron emission tomography (PET) and single-photon...
Neuraceq, florbetaben, F18, F-18, Piramal, alzheimer's
The U.S. Food and Drug Administration (FDA) has approved a third beta-amyloid plaque positron emission tomography (PET) imaging radiotracer to identify...
An international research team at Icahn School of Medicine at Mount Sinai is testing a sugar-based tracer contrast agent to be used with ...

Video Center

The Society of Cardiovascular Computed Tomography (SCCT) annual meeting July 10-13 in San Diego...
4 weeks 6 days ago
There were several new cardiovascular ultrasound technology advances highlighted at the American...
8 weeks 6 hours ago
Call-backs have always been a problem in mammography. They are a source of worry, added discomfort...
9 weeks 6 hours ago
This CME-credit webinar will explore the role of modern imaging modalities, especially MRI, in all steps of interstitial brachytherapy. It will define the role...
This webinar will allow clinicians to learn more about the breast imaging application available with GE Healthcare's unified Web-based viewer. Available...
The webinar "PET/CT: A New Frontier" discusses potential benefits of digital relative to analog PET/CT. The session will discuss how digital PET can improve...

Comparison Charts

Sorry there is no data available